EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Design, synthesis, and anticancer evaluation of novel coumarin/thiazole congeners as potential CDK2 inhibitors with molecular dynamics

Samir Bondock iD, Nada Alabbad, Aisha Hossan, Moaz M Abdou iD, Ali A Shati, Mohammad Y Alfaifi, Serag E I Elbehairi, Nada M Mohamed iD

RSC Advances · 2024 · 14 (27) · 18838-18855

DOI: 10.1039/d4ra02456g ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2024. Verfasst von Samir Bondock und 7 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Faculty of Science, King Khalid University 9004 Abha Saudi Arabia bondock@kku.edu.sa bondock@mans.edu.eg. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: King Khalid University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of novel coumarin–thiazoles was designed and synthesized as a possible CDK2 inhibitor with anticancer activity with low toxicity.

Autor:innen und Institutionen

  • Chemistry Department, Faculty of Science, King Khalid University 9004 Abha Saudi Arabia bondock@kku.edu.sa bondock@mans.edu.eg.
  • Egyptian Petroleum Research Institute Nasr City 11727 Cairo Egypt.
  • Biology Department, Faculty of Science, King Khalid University 9004 Abha Saudi Arabia.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Modern University for Technology and Information, MTI Cairo Egypt.

ORCID-Profile: Samir Bondock, Moaz M Abdou, Nada M Mohamed

Förderung

  • King Khalid University

Zitieren

APA

Bondock, S., Alabbad, N., Hossan, A., Abdou, M. M., Shati, A. A., Alfaifi, M. Y., Elbehairi, S. E. I., & Mohamed, N. M. (2024). Design, synthesis, and anticancer evaluation of novel coumarin/thiazole congeners as potential CDK2 inhibitors with molecular dynamics. RSC Advances, 14(27), 18838-18855. https://doi.org/10.1039/d4ra02456g

Vancouver

Bondock S, Alabbad N, Hossan A, Abdou MM, Shati AA, Alfaifi MY, et al. Design, synthesis, and anticancer evaluation of novel coumarin/thiazole congeners as potential CDK2 inhibitors with molecular dynamics. RSC Advances. 2024;14(27):18838-18855. doi:10.1039/d4ra02456g

BibTeX
@article{Bondock2024,
  author = {Bondock, Samir and Alabbad, Nada and Hossan, Aisha and Abdou, Moaz M and Shati, Ali A and Alfaifi, Mohammad Y and Elbehairi, Serag E I and Mohamed, Nada M},
  title = {Design, synthesis, and anticancer evaluation of novel coumarin/thiazole congeners as potential CDK2 inhibitors with molecular dynamics},
  journal = {RSC Advances},
  year = {2024},
  volume = {14},
  number = {27},
  pages = {18838--18855},
  doi = {10.1039/d4ra02456g}
}
Kostenlos starten →